Monday, October 20, 2014 4:24:52 PM
How Ebola's 300+ Mutations Could Make The Virus Even Scarier
By Kevin Loria 1 hour ago
Every time the virus makes a copy of itself, there's the possibility that something can change.
The world has never seen an Ebola epidemic like this one.
Instead of improving, the situation is getting worse, with infection rates growing exponentially in three West African countries. The disease is so out of control there that the World Health Organization has said that by early December, there could be 10,000 new Ebola infections every week.
The intensity of the outbreak has prompted some researchers to ask if something is different about the virus this time. After all, the Ebola virus — like all viruses — changes over time.
Is it possible that a recent mutation transformed Ebola into something more contagious?
395 Mutations And Counting
First, to get this out of the way: though it's theoretically possible that the virus could mutate to become airborne, we don't even know if it's physically possible. In the more than 100 years that we've studied viruses, we've never seen a human virus change its mode of transmission.
"That's a genetic leap in the realm of science fiction," Council on Foreign Relations senior fellow Laurie Garrett explains in the Washington Post.
An airborne mutation would require more than a few random changes coming together. Even when researchers have tried to genetically engineer an already deadly virus to go airborne, making those changes also made the virus unable to kill.
But other mutations are possible and with viruses, common. We've seen quite a few already in this outbreak.
Researchers analyzed 99 Ebola virus genomes after taking samples from 78 patients in Sierra Leone in late May and early June of 2014. They added in data from three samples taken in Guinea.
Analyzing the virus genome helped them track how the virus had spread in Sierra Leone. To do this genetic detective work, they looked at mutations in the virus to trace its path. When they compared their current samples to previous data, they were able to track 395 different mutations. If you take into account the number of new cases since then, there have probably been many more.
These results were published in the Sept. 12 issue of Science.
Why Viruses Change
As alarming as that number of changes may seem, viruses mutate when they replicate all the time. When viruses replicate, which is what they do inside a person they've infected, they make copies of their own genetic material.
When making these genetic copies, RNA viruses like Ebola are "notoriously bad" at doing so accurately, according to Vincent Racaniello, a Professor of Microbiology & Immunology at Columbia University's College of Physicians and Surgeons.
"Notoriously bad" here means that they mutate a lot, which can be good for the virus if a change makes the organism better able to survive.
In the case of Ebola viruses, this may explain why different Ebola Zaire outbreaks have had different fatality rates — though many prior outbreaks have been too small to be provide accurate fatality rate data.
Dangerous Mutations
Even without going airborne, there are potentially frightening Ebola mutations.
Peter Jahrling, chief scientist at the National Institute of Allergy and Infectious Diseases, recently told Vox that he thinks it's possible that this strain could be more virulent than in the past — that the virus is replicating more rapidly, meaning there are more viral particles in every drop of bodily fluid.
Ebola is already highly infectious — only a tiny amount of virus is needed to catch it, and one-fifth of a teaspoon of blood may already contain 10 billion viral particles. An increased viral load could make transmission even easier, though direct contact with body fluids would still be a necessary condition.
Another scary possibility is that the proteins in the virus recognized by our immune system could change.
At the moment, people who survive Ebola can't be infected by the same strain again. But a change in those proteins recognized by our immune system would mean the virus might be able to infect survivors again, and would also mean that vaccines in development could be made useless.
This sort of mutation isn't uncommon, according to Harvard geneticist Pardis Sabeti, who was part of the team that analyzed the mutations in this outbreak — and Sabeti told The New York Times that they've seen some evidence that this protein changing might be happening with Ebola, occasionally at least.
But Sabeti and other researchers say that there's no evidence that the virus is fundamentally different in any way or that it will mutate into something different.
Instead, these mutations are standard, just like with all viruses. Ebola is bad enough that no extra explanation is needed, beyond the fact that the outbreak happened in a densely populated place that wasn't prepared for it.
"You've got a fairly standard Ebola virus," Dr. Edward Holmes, a biologist at the University of Sydney in Australia, told the Times. "It's just in the worst possible place."
___________________________________________________________
Echo20
Recent ABUS News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 10:00:18 AM
- Arbutus to Present Imdusiran Data at EASL Congress 2024 • GlobeNewswire Inc. • 05/22/2024 06:00:00 AM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/17/2024 01:03:23 PM
- Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize Value • Business Wire • 05/17/2024 01:00:00 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 05/09/2024 12:00:20 PM
- Arbutus to Participate in Two Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 11:30:00 AM
- Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024 • GlobeNewswire Inc. • 05/02/2024 11:25:00 AM
- Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update • GlobeNewswire Inc. • 04/18/2024 11:30:00 AM
- Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna • GlobeNewswire Inc. • 04/04/2024 12:30:49 PM
- Arbutus to Participate in Two Upcoming Investor Conferences • GlobeNewswire Inc. • 03/08/2024 12:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2024 09:48:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:31:15 PM
- Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 02/29/2024 12:30:00 PM
- Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update • GlobeNewswire Inc. • 02/15/2024 12:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:38:59 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 03:48:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 12:55:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 12:55:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 12:54:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 12:54:09 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:31:16 PM
- Arbutus Announces 2024 Corporate Objectives and Provides Financial Update • GlobeNewswire Inc. • 01/08/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 09:09:10 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM